Table 3.

Cox regression of clinical outcome

	Univariable		Multivariable
	Hazard ratio (95% CI)	p value	Hazard ratio (95% CI)	P-value
NODM
Age	0.988 (0.976–1.000)	0.052
Male gender	1.307 (0.848–2.013)	0.225
Glucose	1.009 (1.006–1.011)	< 0.001	1.009 (1.006–1.011)	< 0.001
Triglyceride	1.001 (1.000–1.002)	0.011	1.001 (1.000–1.002)	0.021
β blocker	0.768 (0.517–1.139)	0.189
Statin type	1.098 (0.808–1.491)	0.551
MACE
Age	1.026 (1.016–1.037)	< 0.001	1.020 (1.009–1.032)	0.001
Male gender	0.964 (0.695–1.336)	0.824
LVEF	0.974 (0.961–0.986)	< 0.001	0.980 (0.966–0.993)	0.003
Glucose	1.003 (1.000–1.006)	0.089
Creatinine	1.155 (1.080–1.235)	< 0.001	1.204 (1.062–1.364)	0.004
LDL cholesterol	0.995 (0.992–0.999)	0.011	0.998 (0.994–1.002)	0.258
Statin type	0.944 (0.727–1.225)	0.662
Ticagrelor or prasugrel	0.685 (0.522–0.899)	0.006	0.784 (0.585–1.051)	0.104
ACEi or ARB	0.761 (0.569–1.018)	0.066
β blocker	0.855 (0.609–1.201)	0.367

ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, LDL low-density lipoprotein, LVEF left ventricle ejection fraction